Kamada Ltd. Total Liabilities 2011-2025 | KMDA

Annual Total Liabilities Kamada Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	32 M	38.5 M	25.7 M	32.6 M	33 M	29.5 M	38.7 M	49.4 M	60.7 M	62.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
62.8 M	25.7 M	40.3 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Cellectis S.A. CLLS	112 M	$ 4.3	12.57 %	$ 116 M	France
Graybug Vision GRAY	4.03 M	$ 0.44	-11.23 %	$ 9.65 M	USA
AgeX Therapeutics AGE	6.61 M	$ 11.3	-10.17 %	$ 12.2 K	-
Galera Therapeutics GRTX	154 M	$ 0.14	-32.59 %	$ 7.61 M	USA
Cyclerion Therapeutics CYCN	55.9 M	$ 2.52	-1.18 %	$ 6.35 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	49.9 M	$ 4.37	-1.58 %	$ 28.1 M	China
Caladrius Biosciences CLBS	5.68 M	$ 0.43	-16.75 %	$ 25.8 M	USA
Sorrento Therapeutics SRNE	617 M	$ 0.27	-29.58 %	$ 126 M	USA
BeiGene, Ltd. BGNE	2.59 B	$ 184.71	0.49 %	$ 251 B	Cayman-islands
Midatech Pharma plc MTP	6.46 M	$ 0.29	-18.52 %	$ 27.3 M	Britain
Aeterna Zentaris AEZS	21.9 M	$ 5.72	5.93 %	$ 314 M	Canada
ContraFect Corporation CFRX	32.5 M	$ 1.47	-5.16 %	$ 5.39 M	USA
Orchard Therapeutics plc ORTX	121 M	$ 4.93	1.02 %	$ 90.8 M	Britain
Advaxis ADXS	7.89 M	$ 0.31	-9.65 %	$ 45.9 M	USA
Heat Biologics, Inc. HTBX	8.7 M	$ 3.93	-5.76 %	$ 99.8 M	USA
La Jolla Pharmaceutical Company LJPC	168 M	$ 6.2	-	$ 154 M	USA
Zymeworks ZYME	140 M	$ 6.42	-	$ 404 M	Canada
Checkmate Pharmaceuticals CMPI	9.38 M	$ 10.5	-	$ 231 M	USA
Kadmon Holdings, Inc. KDMN	46.7 M	$ 9.5	-	$ 1.7 B	USA
BioDelivery Sciences International BDSI	137 M	$ 2.58	-4.8 %	$ 255 M	USA
Zosano Pharma Corporation ZSAN	15.4 M	$ 0.56	7.23 %	$ 2.72 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	$ 0.5	-	$ 7.46 M	Israel
Generation Bio Co. GBIO	172 M	$ 6.33	1.61 %	$ 408 M	USA
Kiromic BioPharma KRBP	21.1 M	$ 3.15	6.61 %	$ 3.08 M	USA
Acceleron Pharma Inc. XLRN	77.2 M	$ 179.68	-	$ 10.9 B	USA
Albireo Pharma ALBO	126 M	$ 44.15	-0.23 %	$ 916 M	USA
Stealth BioTherapeutics Corp MITO	95.5 M	$ 0.32	-	$ 23.9 M	USA
Trillium Therapeutics Inc. TRIL	22 M	$ 18.44	-	$ 1.94 B	Canada
Kaleido Biosciences KLDO	39.5 M	$ 0.29	-3.69 %	$ 12.4 M	USA
Entasis Therapeutics Holdings ETTX	9.71 M	$ 2.19	-	$ 105 M	USA
Heron Therapeutics HRTX	267 M	$ 1.35	2.27 %	$ 206 M	USA
ImmuCell Corporation ICCC	17.6 M	$ 6.59	2.17 %	$ 53.8 M	USA
Humanigen HGEN	58 M	$ 0.04	-81.12 %	$ 4.28 M	USA
Aptinyx APTX	28.4 M	$ 0.06	-39.0 %	$ 4.57 M	USA
Tyme Technologies TYME	8.47 M	$ 0.31	8.07 %	$ 54 M	USA
Keros Therapeutics KROS	44.3 M	$ 15.96	1.98 %	$ 598 M	USA
Forward Pharma A/S FWP	1.07 M	$ 2.64	-0.75 %	$ 18.7 M	Danmark
Krystal Biotech KRYS	109 M	$ 187.18	2.27 %	$ 5.35 B	USA
Kymera Therapeutics KYMR	142 M	$ 56.29	-1.11 %	$ 4.22 B	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	$ 0.39	-	$ 26.5 M	USA
Celyad Oncology SA CYAD	35.1 M	$ 0.47	-	$ 12.5 M	Belgium
Brickell Biotech BBI	6.5 M	$ 2.11	-5.38 %	$ 6.06 M	USA
Genocea Biosciences GNCA	28.9 M	$ 0.05	-15.0 %	$ 3.04 M	USA
Codiak BioSciences CDAK	118 M	$ 0.06	-55.98 %	$ 2.15 M	USA
Concert Pharmaceuticals CNCE	53.1 M	$ 8.37	-	$ 401 M	USA
AIkido Pharma AIKI	7.27 M	$ 3.17	1.93 %	$ 17.4 M	USA
Calithera Biosciences CALA	15.7 M	$ 0.37	-10.95 %	$ 876 K	USA
Forma Therapeutics Holdings FMTX	62.7 M	$ 20.01	-	$ 958 M	USA
Arena Pharmaceuticals ARNA	110 M	$ 49.55	-6.81 %	$ 3.04 B	USA
Sierra Oncology SRRA	13.4 M	$ 54.89	-0.05 %	$ 1.34 B	Canada